Deals, Partnering

Genmab and Seattle Genetics expand antibody-drug conjugate (ADC)

Posted on 19 April 2011

Tags:

Genmab and Seattle Genetics have announced they have entered into a second antibody-drug conjugate (ADC) research collaboration agreement. Read the full press release and deal data on the collaborative R&D agreement

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new1gif
rauconbadgejpg
e78banner300x150animgif